Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial.
Henrotin Y, Gharbi M, Dierckxsens Y, Priem F, Marty M, Seidel L, Albert A, Heuse E, Bonnet V, Castermans C. Henrotin Y, et al. Among authors: dierckxsens y. BMC Complement Altern Med. 2014 May 17;14:159. doi: 10.1186/1472-6882-14-159. BMC Complement Altern Med. 2014. PMID: 24886572 Free PMC article. Clinical Trial.
Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study.
Henrotin Y, Malaise M, Wittoek R, de Vlam K, Brasseur JP, Luyten FP, Jiangang Q, Van den Berghe M, Uhoda R, Bentin J, De Vroey T, Erpicum L, Donneau AF, Dierckxsens Y. Henrotin Y, et al. Among authors: dierckxsens y. Arthritis Res Ther. 2019 Jul 27;21(1):179. doi: 10.1186/s13075-019-1960-5. Arthritis Res Ther. 2019. PMID: 31351488 Free PMC article. Clinical Trial.
Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study.
Sanchez C, Zappia J, Lambert C, Foguenne J, Dierckxsens Y, Dubuc JE, Delcour JP, Gothot A, Henrotin Y. Sanchez C, et al. Among authors: dierckxsens y. Front Pharmacol. 2022 Aug 11;13:931914. doi: 10.3389/fphar.2022.931914. eCollection 2022. Front Pharmacol. 2022. PMID: 36034822 Free PMC article.
The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (Emblica officinalis), walnut (Juglans regia), olive (Olea europaea) and red yeast rice (Monascus purpureus) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia.
Hermans MP, Dierckxsens Y, Janssens I, Seidel L, Albert A, Ahn SA, Rousseau MF, Khan A. Hermans MP, et al. Among authors: dierckxsens y. Front Pharmacol. 2023 Nov 27;14:1280234. doi: 10.3389/fphar.2023.1280234. eCollection 2023. Front Pharmacol. 2023. PMID: 38089061 Free PMC article.
The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study.
Wade U, Pascual-Figal DA, Rabbani F, Ernst M, Albert A, Janssens I, Dierckxsens Y, Iqtadar S, Khokhar NA, Kanwal A, Khan A. Wade U, et al. Among authors: dierckxsens y. Nutrients. 2024 Apr 18;16(8):1204. doi: 10.3390/nu16081204. Nutrients. 2024. PMID: 38674895 Free PMC article.
Potential synergistic antihyperglycemic effects of co-supplemental Amla and Olive extracts in hyperlipidemic adults with prediabetes and type 2 diabetes: results from a real-life clinical study.
Michel P H, Ahn SA, Rousseau MF, Seidel L, Albert A, Janssens I, Dierckxsens Y, Khan A. Michel P H, et al. Among authors: dierckxsens y. Front Nutr. 2024 Oct 3;11:1462292. doi: 10.3389/fnut.2024.1462292. eCollection 2024. Front Nutr. 2024. PMID: 39421612 Free PMC article.
11 results